BioTime Inc. (BTX) Plunges 12.5% on November 12

BioTime Inc. (BTX) Plunges 12.5% on November 12

BioTime Inc. (BTX) had a rough trading day for Monday November 12 as shares tumbled 12.5%, or a loss of $-0.24 per share, to close at $1.68. After opening the day at $1.89, shares of BioTime Inc. traded as high as $1.90 and as low as $1.65. Volume was 895,809 shares over 3,560 trades, against an average daily volume of 505,400 shares and a total float of 126.96 million.

As a result of the decline, BioTime Inc. now has a market cap of $213.3 million. In the last year, shares of BioTime Inc. have traded between a range of $3.16 and $1.80, and its 50-day SMA is currently $2.21 and 200-day SMA is $2.39.

BioTime Inc focuses on regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

BioTime Inc. is based out of Alameda, CA and has some 95 employees. Its CEO is Brian M. Culley.

BioTime Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

error: Content is protected !!